CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $266,000 | -2.2% | 15,375 | 0.0% | 0.00% | – |
Q4 2018 | $272,000 | -49.8% | 15,375 | -48.5% | 0.00% | – |
Q3 2018 | $542,000 | +85.6% | 29,866 | +100.0% | 0.00% | – |
Q2 2018 | $292,000 | +33.9% | 14,933 | -19.2% | 0.00% | – |
Q1 2017 | $218,000 | -9.9% | 18,476 | 0.0% | 0.00% | – |
Q4 2016 | $242,000 | -9.7% | 18,476 | 0.0% | 0.00% | – |
Q3 2016 | $268,000 | +36.0% | 18,476 | +12.2% | 0.00% | – |
Q2 2016 | $197,000 | -35.8% | 16,469 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $307,000 | -1.0% | 16,469 | +14.0% | 0.00% | 0.0% |
Q4 2015 | $310,000 | +26.5% | 14,443 | 0.0% | 0.00% | – |
Q3 2015 | $245,000 | -54.8% | 14,443 | 0.0% | 0.00% | -100.0% |
Q2 2015 | $542,000 | – | 14,443 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|